Journal article · 2026 · Open access

Integrated single-cell and bulk RNA sequencing unravels neutrophil heterogeneity and validates SPP1 as a prognostic biomarker in cervical cancer

Siting Lin, Junlin Zhong, Shengjin Yuan, Manting Su, Yiwang Zhang, Xinling Zhang

BMC Cancer, 26(1) · Published 30 January 2026 · DOI 10.1186/s12885-026-15636-9

Open full textCite this paper

In brief

“Integrated single-cell and bulk RNA sequencing unravels neutrophil heterogeneity and validates SPP1 as a prognostic biomarker in cervical cancer” is a 2026 journal article by Siting Lin and 5 co-authors, published in BMC Cancer. OpenAlex counts 1 citations as of 19 November 2026, which puts it in the top 9% of works published in 2026 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at BMC Cancer.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
1.90
References
49
Authors
6

Abstract

BACKGROUND: Cervical cancer (CC) remains a major global health burden, with tumor microenvironment (TME) plasticity and immune evasion driving its progression. The intricate heterogeneity of neutrophils and their complex crosstalk within the TME remain poorly understood, thereby limiting the development of targeted therapeutic strategies. Single-cell RNA sequencing (scRNA-seq) provides an unprecedented level of resolution for dissecting neutrophil subpopulations and elucidating their roles in CC pathogenesis. METHODS: We integrated scRNA-seq data from CC tissues (GSE208653, n = 5) with bulk RNA-seq cohorts from The Cancer Genome Atlas - Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA-CESC) and Genotype-Tissue Expression (GTEx) database. Using Seurat-based clustering, pseudotime trajectory analysis and CellChat, we mapped neutrophil dynamics and intercellular communication networks. Differentially expressed genes (DEGs) were analyzed using the limma package, followed by Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment analyses. A prognostic model was subsequently constructed via LASSO-Cox regression. Key targets were further validated through both in vitro functional assays, immunohistochemical (IHC) and immunofluorescence (IF) analyses of human pathological specimens. RESULTS: Four functionally distinct neutrophil subtypes, including immature, mature, antitumor, and interferon-stimulated populations, were characterized in CC, demonstrating dynamic heterogeneity during tumorigenesis. Secreted Phosphoprotein 1 (SPP1) was identified as a critical differentially expressed gene, with the SPP1-CD44 axis serving as a key mediator of neutrophil-tumor cell crosstalk. Downregulation of SPP1 markedly suppressed CC cell migration, invasion, and proliferation. Furthermore, a prognostic signature based on risk stratification efficiently categorized patients into high- and low-risk cohorts, with validated clinical utility in predicting survival outcomes. CONCLUSIONS: Our study comprehensively characterized the TME in CC through single-cell transcriptomics. Integrated analysis with bulk RNA-seq established and validated a robust prognostic signature, identifying SPP1 as a key oncogenic driver. The SPP1-centric model demonstrates significant clinical utility for risk stratification. These findings provide new insights into neutrophil heterogeneity and establish a mechanistic foundation for precision therapeutics in CC.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Lin, S., Zhong, J., Yuan, S., Su, M., Zhang, Y., & Zhang, X. (2026). Integrated single-cell and bulk RNA sequencing unravels neutrophil heterogeneity and validates SPP1 as a prognostic biomarker in cervical cancer. BMC Cancer, 26(1). https://doi.org/10.1186/s12885-026-15636-9

MLA 9

Lin, Siting, et al. “Integrated single-cell and bulk RNA sequencing unravels neutrophil heterogeneity and validates SPP1 as a prognostic biomarker in cervical cancer.” BMC Cancer, vol. 26, no. 1, 2026. https://doi.org/10.1186/s12885-026-15636-9.

Chicago

Lin, Siting, Junlin Zhong, Shengjin Yuan, Manting Su, Yiwang Zhang, and Xinling Zhang. 2026. “Integrated single-cell and bulk RNA sequencing unravels neutrophil heterogeneity and validates SPP1 as a prognostic biomarker in cervical cancer.” BMC Cancer 26 (1). https://doi.org/10.1186/s12885-026-15636-9.

Harvard

Lin, S. et al. (2026) ‘Integrated single-cell and bulk RNA sequencing unravels neutrophil heterogeneity and validates SPP1 as a prognostic biomarker in cervical cancer’, BMC Cancer, 26(1). doi:10.1186/s12885-026-15636-9.

IEEE

S. Lin, J. Zhong, S. Yuan, M. Su, Y. Zhang, and X. Zhang, “Integrated single-cell and bulk RNA sequencing unravels neutrophil heterogeneity and validates SPP1 as a prognostic biomarker in cervical cancer,” BMC Cancer, vol. 26, no. 1, 2026, doi: 10.1186/s12885-026-15636-9.

BibTeX

@article{lin2026integrated,
  title     = {{Integrated single-cell and bulk RNA sequencing unravels neutrophil heterogeneity and validates SPP1 as a prognostic biomarker in cervical cancer}},
  author    = {Lin, Siting and Zhong, Junlin and Yuan, Shengjin and Su, Manting and Zhang, Yiwang and Zhang, Xinling},
  journal   = {BMC Cancer},
  year      = {2026},
  volume    = {26},
  number    = {1},
  doi       = {10.1186/s12885-026-15636-9},
  url       = {https://doi.org/10.1186/s12885-026-15636-9}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer

  • cervical cancer
  • neutrophil heterogeneity
  • osteopontin
  • tumor microenvironment
  • prognostic factors
  • prognostic signature
  • risk stratification
  • tumor immune evasion

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Lin, S., Zhong, J., Yuan, S., Su, M., Zhang, Y., & Zhang, X. (2026). Integrated single-cell and bulk RNA sequencing unravels neutrophil heterogeneity and validates SPP1 as a prognostic biomarker in cervical cancer. BMC Cancer, 26(1). https://doi.org/10.1186/s12885-026-15636-9

How many times has this paper been cited?

1 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at BMC Cancer: sign in and open the full text from this page.

Who wrote this paper?

Siting Lin, Junlin Zhong, Shengjin Yuan, Manting Su, Yiwang Zhang, Xinling Zhang.

What is the DOI of this paper?

10.1186/s12885-026-15636-9, permanently at https://doi.org/10.1186/s12885-026-15636-9. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.